13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 25 holding rows worth $1,722,216,880.
- Accession
- 0001388325-26-000042
- Filer
- CIK 1388325
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 25 entries on the cover page, a total value of $1,722,216,880 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,722,216,880 with VALUE read as dollars as filed, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 5,350,000 | $217,370,500 | dollars as filed | |
| ASMLHLDGNVFSPONSOREDADR1ADRREPS1ORDSHS | N07059210 | STOK | 94,946 | $188,889,370 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 4,180,550 | $153,551,602 | dollars as filed | |
| BROOKFIELD CORP CL A LTD VT SH | 11271J107 | Stock | 3,496,245 | $149,534,399 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 3,686,622 | $132,128,532 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 1,125,000 | $131,703,750 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 3,883,289 | $127,837,874 | dollars as filed | |
| Salesforce.com, Inc | 79466L302 | COM | 393,187 | $61,596,675 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,500,000 | $52,110,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,000,000 | $50,750,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 1,320,000 | $49,394,400 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,400,000 | $48,412,000 | dollars as filed | |
| FLOOR & DECOR HLDGS INC CL A | 339750101 | Stock | 797,000 | $47,309,920 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 800,000 | $46,504,000 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 3,249,178 | $43,214,067 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,135,000 | $39,219,950 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 1,025,000 | $38,140,250 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 1,100,000 | $30,954,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 485,438 | $29,301,038 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 257,327 | $24,698,245 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 960,394 | $21,330,351 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 2,250,000 | $17,145,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 120,723 | $12,871,486 | dollars as filed | |
| MARQETA INC | 57142B104 | CLASS A COM | 441,558 | $7,170,902 | dollars as filed | |
| LANZATECH GLOBAL INC | 51655R200 | CMN | 158,148 | $1,078,569 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001388325-26-000042 | this filing | 2026-08-14 | acceptance time not in the bulk data set |